Document Preview Unavailable
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency
Werner-Klein, Melanie; Grujovic, Ana; Irlbeck, Christoph; Obradovic, Milan; Hoffmann, Martin; et al. bioRxiv, May 30, 2020.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library